By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366



Company News
Bayer (BAY) Release: Health Canada Approves New Treatment Option For Canadian Adults and Children Living with Hemophilia A 2/3/2016 6:20:58 AM
Avioq Obtains Health Canada Approval For Screening Of Cadaveric Organ And Tissue Donors With The Avioq HTLV-I/II Microelisa System, Expands Already Approved Health Canada And CE-IVD Claims 1/28/2016 10:19:08 AM
Health Canada Approves Amgen (AMGN)'s New Multiple Myeloma Treatment Kyprolis (carfilzomib) 1/28/2016 5:59:29 AM
Vertex (VRTX) Release: Health Canada Approves PrORKAMBI (Lumacaftor/Ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation 1/27/2016 10:19:29 AM
Janssen Inc. Release: Health Canada Approves Stelara As First Biologic In North America For The Treatment Of Moderate-To-Severe Psoriasis In Adolescents 1/13/2016 7:31:21 AM
Health Canada Approves Amgen (AMGN)'s BLINCYTO (blinatumomab) For The Treatment Of Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia 1/12/2016 6:34:39 AM
Baxalta (BXLT) Announces Priority Review Status Granted By Health Canada For Irinotecan Liposome Injection (Nal-IRI) For New Drug Submission 1/7/2016 12:26:19 PM
AbbVie (ABBV)'s HUMIRA (Adalimumab) Receives First And Only Health Canada Approval For Moderate To Severe Hidradenitis Suppurativa 1/6/2016 6:40:33 AM
Health Canada Issues Notice Of Compliance For Gilead (GILD)’s Single Tabletregimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofoviralafenamide) For Treatment Of HIV-1 Infection 12/7/2015 1:27:37 PM
Cipher Pharma (DND.TO) Receives Health Canada Approval Of (Pr)Beteflam 12/7/2015 6:37:39 AM